EUVIMEDEUVIMED entdecken
Crossref

Real World Data of Emicizumab Prophylaxis in Young Children with Severe Hemophilia A Without Inhibitors

Sanjeev Khera, Renjith Mathew Verghese, M. K. Safal Muhammed, Preeti Tripathi, Mridula Nair, Rajiv Kumar, Rajan Kapoor

Indian Journal of Hematology and Blood Transfusion · 29.04.2026

DOI: 10.1007/s12288-026-02428-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Hematology and Blood Transfusion, online erschienen am 29.04.2026. Verfasst von Sanjeev Khera und 6 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Khera, S., Verghese, R. M., Muhammed, M. K. S., Tripathi, P., Nair, M., Kumar, R., & Kapoor, R. (2026). Real World Data of Emicizumab Prophylaxis in Young Children with Severe Hemophilia A Without Inhibitors. Indian Journal of Hematology and Blood Transfusion. https://doi.org/10.1007/s12288-026-02428-1

Vancouver

Khera S, Verghese RM, Muhammed MKS, Tripathi P, Nair M, Kumar R, et al. Real World Data of Emicizumab Prophylaxis in Young Children with Severe Hemophilia A Without Inhibitors. Indian Journal of Hematology and Blood Transfusion. 2026. doi:10.1007/s12288-026-02428-1

BibTeX
@article{Khera2026,
  author = {Khera, Sanjeev and Verghese, Renjith Mathew and Muhammed, M. K. Safal and Tripathi, Preeti and Nair, Mridula and Kumar, Rajiv and Kapoor, Rajan},
  title = {Real World Data of Emicizumab Prophylaxis in Young Children with Severe Hemophilia A Without Inhibitors},
  journal = {Indian Journal of Hematology and Blood Transfusion},
  year = {2026},
  doi = {10.1007/s12288-026-02428-1}
}
Kostenlos starten →